top of page
shutterstock_1912524370.jpg

Empowering Leading Companies to Ignite Innovations into Industrial Milestones

We provide high-value temporary resources to companies and academia for R&D and BD scopes

Access to specialized expertise

Enhanced KOL and stakeholder engagement

A holistic project approach

Accelerated product development and time-to-Market

Strategic positioning in competitive landscape 

R&D masterplan value-driven and aligned with end-user expectations.

Trending Topics

Catalyzing Cross-Industry Innovation Through Strategic R&D Partnerships

In the fast-paced world of innovation, bridging the gap between groundbreaking research and its application across industries requires not just expertise, but a visionary approach to collaboration. For over two decades, Chelonia has led the charge in forging such transformative partnerships. Our mission is clear: to assist diverse industries in harnessing the power of scientific research, turning it into the engine of their R&D platforms and driving forward their industrial solutions.

Trusted Among Leaders 

Established in 2002, Chelonia is a renowned partner for top organizations, driving industry-wide success and innovation through selective, high-impact public-private collaborations.
 

2560px-AstraZeneca_logo.svg.png
Logo_Bayer.svg.png
Dompe_Farmaceutici_Logo.jpg
5.jpg
png-transparent-eni-hd-logo-thumbnail.png
14.jpg
23.jpg
1.jpg
8.jpg
Logo_Sanofi_(2022).png
6.jpg
10.jpg
2.jpg
Pfizer_(2021).png
Remedi4Alllogo.png

Mastering KOL Engagement: The Keystone of Innovation Strategy

Revolutionize your project roadmaps with our expertise in cutting-edge scientific research methodologies and strategic development planning. Our unique selling proposition lies in in our specialized approach to KOL engagement and stakeholder management, ensuring your innovations are informed by the latest industry insights and supported by key industry figures.

Featured Collaborative Innovators

Dedication. Expertise. Passion.

Highlighting a selection of distinguished contributors from our extensive network of global experts

Arieh Warshel

Nobel Prize-Winning Chemist 2013

Piero Carninci

Human Technolpole and RIKEN 

Zsolt Lavotha

Strategic Advisor and former Pfizer Chairman

Torsten Schwede

University of Basel

Igor V. Tetko

Helmholtz Zentrum München
Institute of Structural Biology

Gary Pisano

Harvard Business School

James Beacham

ATLAS, CERN

Manuel C. Peitsch

DrugReKindle Initiative at Chelonia SA

Sabra Klein

Johns Hopkins Bloomberg School of Public Health

Chelonia Registered in Lugano
bottom of page